当前位置: 首页 > 期刊 > 《医学信息》 > 202015
编号:13844730
低氧性肺动脉高压肺血管重塑机制的研究(5)
http://www.100md.com 2020年4月16日 《医学信息》 202015
     [31]Dannewitz Prosseda S,Tian X,Kuramoto K,et al.FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension[J].Am J RespirCrit Care Med,2019,199(1):83-98.

    [32]Archer SL.Mitochondrial dynamics--mitochondrial fission and fusion in human diseases[J].N Engl J Med,2013,369(23):2236-2251.

    [33]Yu Q,Tai YY,Tang Y,et al.BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension[J].Circulation,2019,139(19):2238-2255.

    [34]Yu Q,Tai YY,Tang Y,et al.BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension[J].Circulation,2019,139(19):2238-2255.

    [35]Stenmark KR,Tuder RM,ElKasmi KC.Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension[J].J ApplPhysiol,2015,119(10):1164-1172.

    [36]Cameron JM,Janer A,Levandovskiy V,et al.Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes[J].Am J Hum Genet,2011,89(4):486-495.

    [37]徐欣元,沈嵐,药立波.肿瘤代谢重编程中的癌基因与抑癌基因[J].中国生化药物杂志,2016(9):1-5.

    收稿日期:2020-05-18;修回日期:2020-05-28

    编辑/杜帆, http://www.100md.com(李宜桐 李勇)
上一页1 2 3 4 5